1. Home
  2. ZURA vs NEOV Comparison

ZURA vs NEOV Comparison

Compare ZURA & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • NEOV
  • Stock Information
  • Founded
  • ZURA 2022
  • NEOV 2018
  • Country
  • ZURA United States
  • NEOV United States
  • Employees
  • ZURA N/A
  • NEOV N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • NEOV Industrial Machinery/Components
  • Sector
  • ZURA Health Care
  • NEOV Miscellaneous
  • Exchange
  • ZURA Nasdaq
  • NEOV Nasdaq
  • Market Cap
  • ZURA 76.6M
  • NEOV 72.2M
  • IPO Year
  • ZURA N/A
  • NEOV N/A
  • Fundamental
  • Price
  • ZURA $1.01
  • NEOV $3.35
  • Analyst Decision
  • ZURA Buy
  • NEOV Strong Buy
  • Analyst Count
  • ZURA 7
  • NEOV 1
  • Target Price
  • ZURA $14.33
  • NEOV $7.50
  • AVG Volume (30 Days)
  • ZURA 520.6K
  • NEOV 198.6K
  • Earning Date
  • ZURA 05-08-2025
  • NEOV 05-09-2025
  • Dividend Yield
  • ZURA N/A
  • NEOV N/A
  • EPS Growth
  • ZURA N/A
  • NEOV N/A
  • EPS
  • ZURA N/A
  • NEOV N/A
  • Revenue
  • ZURA N/A
  • NEOV $4,255,136.00
  • Revenue This Year
  • ZURA N/A
  • NEOV $208.50
  • Revenue Next Year
  • ZURA N/A
  • NEOV $128.75
  • P/E Ratio
  • ZURA N/A
  • NEOV N/A
  • Revenue Growth
  • ZURA N/A
  • NEOV 52.64
  • 52 Week Low
  • ZURA $0.97
  • NEOV $1.80
  • 52 Week High
  • ZURA $5.56
  • NEOV $6.11
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 35.69
  • NEOV 56.56
  • Support Level
  • ZURA $0.99
  • NEOV $2.76
  • Resistance Level
  • ZURA $1.06
  • NEOV $3.74
  • Average True Range (ATR)
  • ZURA 0.08
  • NEOV 0.32
  • MACD
  • ZURA -0.01
  • NEOV -0.00
  • Stochastic Oscillator
  • ZURA 7.17
  • NEOV 60.20

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.

Share on Social Networks: